HYDROFARM HOLDINGS GROUP, INC. quarterly report, Q1 FY2022

Hydrofarm Holdings Group, Inc. — Q1 2022 Form 10-Q

Reporting period: Three months ended March 31, 2022. Hydrofarm manufactures and distributes controlled-environment agriculture (CEA) equipment and supplies, primarily in the U.S. and Canada. Results include five businesses acquired during 2021; the comparable 2021 quarter did not include those acquisitions for the full period.

Financial results and liquidity

MetricQ1 2022Q1 2021
Net sales$111.4 million$111.4 million
Gross profit / margin$16.6 million / 14.9%$23.2 million / 20.8%
Operating income (loss)$(26.4) million$6.4 million
Net income (loss)$(23.3) million$4.9 million
Diluted EPS$(0.52)$0.13
Adjusted EBITDA, non-GAAP$3.1 million (2.8% of sales)$9.9 million (8.9% of sales)
Cash used in operating activities$10.2 million$2.6 million

At March 31, 2022, cash and cash equivalents were $12.2 million, with an additional $1.8 million of restricted cash. Working capital was $261.0 million of current assets against $88.9 million of current liabilities. Total debt was $121.5 million, including a $125 million senior secured term loan before unamortized discount and financing costs. The company reported approximately $99.7 million available under its $100 million revolving facility and compliance with debt covenants.

Material changes and drivers

  • Sales were essentially flat year over year. Management attributed this to a 2.1% decline in product volume, including a 36.7% decline in organic sales partly offset by 34.6% growth from recently acquired proprietary brands; higher price and mix offset much of the volume decline.
  • Gross profit fell 28.5%, and gross margin declined 5.9 percentage points. Management cited higher freight and labor costs, purchase-accounting inventory adjustments, and a $3.2 million increase in inventory-obsolescence allowance, mainly for slow-moving lighting products. Price increases and a higher mix of proprietary brands partly offset these pressures.
  • SG&A rose to $43.0 million from $16.8 million, driven chiefly by acquisition-related intangible amortization, including $5.9 million of catch-up amortization from revised useful-life estimates; compensation and stock-based compensation; a $2.6 million note-receivable impairment; facility and relocation costs; and acquisition and integration expenses.
  • Interest expense increased to $2.4 million from $0.1 million as the term loan was outstanding throughout the quarter. The $5.6 million income-tax benefit included benefits related to the IGE acquisition and purchase-price allocation adjustments.
  • Cash declined by $14.5 million during the quarter. Operating cash use included a $9.1 million working-capital use, principally higher receivables and lower deferred revenue, partly offset by higher accounts payable. Investing cash use was $2.4 million, primarily for property and equipment.

Outlook, risks and unusual items

  • The filing provides no quantitative revenue, earnings, or cash-flow guidance. Management described the sales-volume weakness as potentially short-term and linked it to oversupply that pressured cannabis-growing activity, particularly in California and Canada.
  • Management reported extended supply-chain lead times and increased shipping costs, and cautioned that renewed COVID-19 disruptions, supplier price increases, or inability to obtain inventory could affect operations and margins.
  • Other identified exposures include competition and industry consolidation, customer conditions and crop economics, cannabis regulation, acquisition integration, variable interest rates, and foreign currency movements. The company reported $124.7 million of variable-rate debt exposure; a 100-basis-point rate increase above applicable floors would add about $1.1 million to annual interest expense. It does not currently hedge interest-rate risk.
  • Unusual or significant items included a $2.6 million impairment of a note receivable after the borrower defaulted on interest payments; increased inventory reserves; acquisition-related purchase accounting and amortization; and contingent acquisition consideration. Current accrued contingent consideration was $15.5 million. Goodwill fell from $204.9 million to $183.3 million, mainly from an IGE purchase-price remeasurement; management identified no goodwill impairment trigger requiring a quantitative test at quarter-end.
  • The company entered a lease for approximately 303,000 square feet of warehouse space, recording $10.5 million of operating lease right-of-use assets. It also disclosed $40.9 million of future minimum payments for executed leases not yet commenced. Management said it was unaware of legal proceedings expected to have a material adverse effect; it reported no material risk-factor changes from its 2021 Form 10-K.

Important facts for investors to verify

  • Whether organic demand and product volumes stabilize, and whether acquired-brand growth can continue to offset organic declines.
  • Whether gross margins recover as freight, labor, inventory-obsolescence, and purchase-accounting pressures change.
  • The recurring cash-earning capacity behind reported results, given lower Adjusted EBITDA, operating cash use, and substantial amortization and other adjustments.
  • The value and collectability of the impaired note receivable, the remaining contingent acquisition payments, and the final acquisition accounting and intangible-asset useful lives.
  • Liquidity and debt-service capacity, including variable-rate exposure, covenant requirements, lease commitments, and available revolver capacity.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.